Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Chikungunya virus impairs draining lymph node function by inhibiting HEV-mediated lymphocyte recruitment
Mary K. McCarthy, Bennett J. Davenport, Glennys V. Reynoso, Erin D. Lucas, Nicholas A. May, Susan A. Elmore, Beth A. Tamburini, Heather D. Hickman, Thomas E. Morrison
Mary K. McCarthy, Bennett J. Davenport, Glennys V. Reynoso, Erin D. Lucas, Nicholas A. May, Susan A. Elmore, Beth A. Tamburini, Heather D. Hickman, Thomas E. Morrison
View: Text | PDF
Research Article Immunology Infectious disease

Chikungunya virus impairs draining lymph node function by inhibiting HEV-mediated lymphocyte recruitment

  • Text
  • PDF
Abstract

Chikungunya virus (CHIKV) causes acute and chronic rheumatologic disease. Pathogenic CHIKV strains persist in joints of immunocompetent mice, while the attenuated CHIKV strain 181/25 is cleared by adaptive immunity. We analyzed the draining lymph node (dLN) to define events in lymphoid tissue that may contribute to CHIKV persistence or clearance. Acute 181/25 infection resulted in dLN enlargement and germinal center (GC) formation, while the dLN of mice infected with pathogenic CHIKV became highly disorganized and depleted of lymphocytes. Using CHIKV strains encoding ovalbumin-specific TCR epitopes, we found that lymphocyte depletion was not due to impaired lymphocyte proliferation. Instead, the accumulation of naive lymphocytes transferred from the vasculature to the dLN was reduced, which was associated with fewer high endothelial venule cells and decreased CCL21 production. Following NP-OVA immunization, NP-specific GC B cells in the dLN were decreased during pathogenic, but not attenuated, CHIKV infection. Our data suggest that pathogenic, persistent strains of CHIKV disable the development of adaptive immune responses within the dLN.

Authors

Mary K. McCarthy, Bennett J. Davenport, Glennys V. Reynoso, Erin D. Lucas, Nicholas A. May, Susan A. Elmore, Beth A. Tamburini, Heather D. Hickman, Thomas E. Morrison

×

Figure 4

Lymphocyte proliferation in the dLN is similar during acutely cleared and pathogenic CHIKV infection.

Options: View larger image (or click on image) Download as PowerPoint
Lymphocyte proliferation in the dLN is similar during acutely cleared an...
(A) Representative FACS plots and (B) number of SIINFEKL tetramer+ CD8+ T cells in the spleen of WT C57BL/6 mice (n = 9 per group) at 7 dpi. (C–E) WT C57BL/6 mice (n = 8 per group) were mock infected or infected with 103 PFU 181/25.OVA or AF15561.OVA and the dLN was excised at 5 dpi. (C) Frequency of CD8+ SIINFEKL tetramer+ cells (top panels) and Ki67+ of total CD8+ cells or tetramer+ cells (bottom panels). (D) Number of SIINFEKL tetramer+ CD8+ T cells. (E) Percentage of CD8+ SIINFEKL tetramer+ cells expressing Ki67. Data are combined from 2 independent experiments. (F) Enriched CD4+ T cells (105) from CD45.1+ OT-II mice were transferred i.v. into CD45.2+ recipients (n = 4 per group) 4 hours prior to inoculation with 103 PFU 181/25.OVA or AF15561.OVA and the dLN was collected at 4 dpi. (G) FACS plots showing Ki67+ OT-II cells. (H) Number of transferred OT-II cells per dLN. (I) Percentage of Ki67+ OT-II cells. Data are representative of 2 independent experiments. Each bar represents the mean ± SEM. *P < 0.05, ***P < 0.001; Mann-Whitney test (E and F), or 1-way ANOVA with Tukey’s multiple-comparisons test (A–C, I, and J).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts